1Antman K,etal.ASouthwestoncologygroup and cancerandleukem ia group B phase e study of doxo rubicin,dacarbazine,ifo sfamide,and mesna in adults with advanced o steo sarcoma,Ewings sarco-ma,and rhabadomyo sarcoma[].Cancer.1998
2Garzotto CK,BergJ,Hoffmann WE,et al. Journal of Veterinary Internal Medicine . 2000
3Bacci G,et al.Neoadjuvant chemo therapy for extremity osteosarcoma -prelim inary results of the Rizzo li’s 4th study[].A cta Onco l.1998
同被引文献12
1Holmboe L,Andersen AM,Morkrid L,et al. High dose methotrex-ate chemotherapy : pharmacokinetics, folate and toxicity in osteosar-coma patients[ J]. Br J ClinPharmacol ,2009,73 (1 ) :106-114.
2Kudawara I, Aoki Y, Ueda T,et al. Neodjuvant and adjuvant chemo-therapy with high-dose ifosfamine, doxorubicin, cisplatin and high-dose methotrexate in non-metastatic osteosarcoma of the extremities:a phase II trial in Japan[ J]. J Chemother,2013 ,25 (1) :41-48.
